Patent · US Expired

Adamantane-piperazine derivatives

US4001223A · kind A · utility

11Cited by
9References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 16, 1975
Grant dateJan 4, 1977
Priority date
Expiry dateDec 16, 1995

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D295/03
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Adamantane derivatives of this invention are represented by the formula ##STR1## wherein R.sub.1 is ##STR2## or --CH.sub.2 -- and R.sub.2 is ##STR3## or --CH.sub.2 CH=CH--. Said derivatives are cerebral vasodilators or intermediates for the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.